BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36847075)

  • 1. Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach.
    Kumar U; Aich J; Devarajan S
    Anticancer Drugs; 2023 Nov; 34(10):1094-1103. PubMed ID: 36847075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Clin Cardiol; 2011 Apr; 34(4):261-5. PubMed ID: 21432858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for hypertension.
    Med Lett Drugs Ther; 2020 May; 62(1598):73-80. PubMed ID: 32555118
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
    Xie M; Tang T; Liang H
    Clin Cardiol; 2023 Aug; 46(8):886-898. PubMed ID: 37432701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current position of a fixed combination telmisartan with amlodipine in treatment of essential arterial hypertension].
    Slíva J
    Vnitr Lek; 2016; 62(9):699-702. PubMed ID: 27715071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of telmisartan and atenolol in management of essential hypertension.
    Khan P; Khan W; Abbasi A; Ahad A; Khan M; Ahmad Y; Ahmad A
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):36-8. PubMed ID: 24669604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension.
    Zhao D; Liu H; Dong P
    Clin Exp Hypertens; 2019; 41(1):75-79. PubMed ID: 29589977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of telmisartan in the treatment of hypertension.
    White WB
    J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.
    Jo SH; Park SJ; Hong GR; Kim SW; Park CG
    Adv Ther; 2021 Jan; 38(1):304-315. PubMed ID: 33108624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan.
    McClellan KJ; Markham A
    Drugs; 1998 Dec; 56(6):1039-44; discussion 1045-6. PubMed ID: 9878991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
    Suárez C
    Drugs; 2011 Dec; 71(17):2295-305. PubMed ID: 22085386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
    Marketou ME; Kontaraki JE; Tsakountakis NA; Zacharis EA; Kochiadakis GE; Arfanakis DA; Parthenakis F; Chlouverakis G; Vardas PE
    Am J Cardiol; 2011 Jan; 107(1):59-63. PubMed ID: 21146687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
    Zhang ZL; Li HL; Wen ZP; Yang GP; Zhang W; Chen XP
    Chin Med J (Engl); 2016 Jan; 129(1):8-14. PubMed ID: 26712426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.
    Watanabe M; Inukai K; Sumita T; Ikebukuro K; Ito D; Kurihara S; Ono H; Awata T; Katayama S
    Intern Med; 2010; 49(17):1843-7. PubMed ID: 20823643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
    Plosker GL; White WB
    Drugs; 2008; 68(13):1877-99. PubMed ID: 18729541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
    Nedogoda SV; Ledyaeva AA; Chumachok EV; Tsoma VV; Mazina G; Salasyuk AS; Barykina IN
    Clin Drug Investig; 2013 Aug; 33(8):553-61. PubMed ID: 23800977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.